The GVAX cancer vaccine plus ipilimumab is active in the treatment of patients with advanced prostate cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1577, 2007-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer vaccine-GVAX: potential in NSCLC

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 10-10 (1)

Adis International

Access to resources Recommend Favorite

Pertuzumab is active in the treatment of patients with advanced cancer

By  

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 9-9 (1)

Adis International

Access to resources Recommend Favorite

Doxorubicin plus Ifosfamide as Salvage Treatment for Patients with Advanced Breast Cancer Refractory to Epirubicin plus Cyclophosphamide

By Polyzos A.  

Clinical Drug Investigation, Vol. 19, Iss. 5, 2000-05 ,pp. : 349-355 (7)

Adis International

Access to resources Recommend Favorite

Personalized Peptide Vaccine for Treatment of Advanced Cancer

By  

Current Medicinal Chemistry, Vol. 21, Iss. 21, 2014-07 ,pp. : 2332-2345 (14)

Bentham Science Publishers

Access to resources Recommend Favorite

The Treatment of Advanced Prostate Cancer with Ketoconazole: Safety Issues

By Bok R.A.   Small E.J.  

Drug Safety, Vol. 20, Iss. 5, 1999-05 ,pp. : 451-458 (8)

Adis International

Access to resources Recommend Favorite